β-Hydroxy-β-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitro

Nutrition

Volumn 27, Issue 1, 2011, Pages 92-99

  Nunes, Everson A ^a   Lomax, Amy R ^b   Noakes, Paul S ^b   Miles, Elizabeth A ^b   Fernandes, Luiz C ^a   Calder, Philip C ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cell cycle; Cytokines; HMB; Immunomodulation; Lymphocyte; Proliferation

Indexed keywords

BETA HYDROXY BETA METHYLBUTYRIC ACID; CYTOKINE; IMMUNOMODULATING AGENT; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CELL CYCLE; CELL PROLIFERATION; CONCANAVALIN A; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; VALERATES; YOUNG ADULT;

EID: 78649976047     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2009.12.008     Document Type: Article

References (32)

1. Calder P.C. Immunonutrition in surgical and critically ill patients. Br J Nutr 2007, 98:S133-S139.
2. Irwin M.R. Human psychoneuroimmunology: 20 years of discovery. Brain Behav Immun 2007, 22:129-139.
3. Calder P.C., Kew S. The immune system: a target for functional foods?. Br J Nutr 2002, 88:S165-S177.
4. Kuhls D.A., Rathmacher J.A., Musngi M.D., Frisch D.A., Nielson J., Barber A., et al. Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. J Trauma 2007, 62:125-131.
5. Calder P.C. Branched-chain amino acids and immunity. J Nutr 2006, 136:288S-293S.
6. Nonnecke B.J., Franklin S.T., Nissen S.L. Leucine and its catabolites alter mitogen-stimulated DNA synthesis by bovine lymphocytes. J Nutr 1991, 121:1665-1672.
7. Nissen S.L., Abumrad N.N. Nutritional role of the leucine metabolite β-hydroxy-β-methylbutyrate (HMB). Nutr Biochem 1997, 8:300-311.
8. Siwicki A.K., Fuller J.C., Nissen S., Morand M., Pozet F., Vincent F., et al. Effect of HMB (β-hydroxy- β-methylbutyrate) on in vitro proliferative responses of sheatfish (Silurius glanis) and catfish (Ictalurus melas) lymphocytes stimulated by mitogens. Acta Vet Brno 2004, 73. 1991-22.
9. Siwicki A.K., Morand M., Fuller J.C., Nissen S., Kazun K., Glombski E. In vitro effects of β-hydroxy-β-methylbutyrate (HMB) on cell-mediated immunity in fish. Vet Immunol Immunopatol 2000, 76:191-197.
10. Siwicki A.K., Zdziszaw Z., Fuller J.C., Nissen S., Trapkowska S., Gzabski E., et al. The effect of feeding the leucine metabolite b-hydroxy-b-methylbutyrate (HMB) on cell-mediated immunity and protection against Yersinia ruckeri in pikeperch (Sander lucioperca). Aquac Res 2005, 36:16-21.
11. Siwicki A.K., Zakes Z., Fuller J.C., Nissen S., Kazun K., Glabski E. The influence of β-hydroxy-β-methylbutyrate (HMB) on cell-mediated immunity in tench Tinca tinca (L.): in vitro and in vivo. Aquac Int 2006, 14:153-161.
12. Siwicki A.K., Morand M., Fuller J., Nissen S., Goryczko K., Ostaszewski P., et al. Influence of feeding the leucine metabolite β-hydroxy-β-methylbutyrate (HMB) on the non-specific cellular and humoral defense mechanisms of rainbow trout (Oncorhynchus mykiss). J Appl Ichthyol 2003, 19:44-48.
13. Gatnau R., Zimmerman D.R., Nissen S.L., Wannemuehler M., Ewan R.C. Effects of excess dietary leucine and leucine catabolites on growth and immune responses in weanling pigs. J Anim Sci 1995, 73:159-165.
14. Kuhlman G., Roth J.A., Flakoll P.J., Vandehaar M.J., Nissen S. Effects of dietary leucine, alpha-ketoisocaproate and isovalerate on antibody production and lymphocyte blastogenesis in growing lambs. J Nutr 1998, 118:1564-1569.
15. Gallagher P.M., Carrithers J.A., Godard M.P., Schulze K.E., Trappe S.W. β-hydroxy-β-methylbutyrate ingestion, Part I: effects on strength and fat free mass. Med Sci Sports Exerc 2000, 32:2109-2115.
16. Eley H.L., Russell S.T., Tisdale M.J. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate. Am J Physiol Endocrinol Metab 2008, 295:E1417-E1426.
17. Eley H.L., Russell S.T., Tisdale M.J. Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate. Am J Physiol Endocrinol Metab 2008, 295:E1409-E1416.
18. Kornasio R., Riederer I., Butler-Browne G., Mouly V., Uni Z., Halevy O. beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 2009, 1793:755-763.
19. Li Y.Q., Hii C.S., Der C.J., Ferrante A. Direct evidence that ERK regulates the production/secretion of interleukin-2 in PHA/PMA-stimulated T lymphocytes. Immunology 1999, 96:524-528.
20. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Meth 2000, 243:147-154.
21. Telford W.G., King L.E., Fraker P.J. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 1991, 24:447-459.
22. Clark R.H., Feleke G., Din M., Yasmin T., Singh G., Khan F.A., et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. J Parenter Enteral Nutr 2000, 24:133-139.
23. Marcora S., Lemmey A., Maddison P. Dietary treatment of rheumatoid cachexia with b-hydroxy-b-methylbutyrate, glutamine and arginine: A randomized controlled trial. Clin Nutr 2005, 24:442-454.
24. May P.E., Barber A., D'Olimpio J.T., Hourihane A., Abumrad N.N. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 2002, 183:471-479.
25. Vukovich M.D., Slater G., Macchi M.B., Turner M.J., Fallon K., Boston T., et al. Beta-hydroxy-beta-methylbutyrate (HMB) kinetics and the influence of glucose ingestion in humans. J Nutr Biochem 2001, 12:631-639.
26. Delves P.J., Roitt I.M. The immune system. First of two parts. N Engl J Med 2000, 6(343):37-49.
27. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007, 117:1175-1183.
28. Gorjão R., Hirabara S.M., de Lima T.M., Cury-Boaventura M.F., Curi R. Regulation of interleukin-2 signaling by fatty acids in human lymphocytes. J Lipid Res 2007, 48:2009-2019.
29. Gesbert F., Moreau J.L., Thèze J. IL-2 responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2R-beta transgenic mice. Int Immunol 2005, 17:1093-1102.
30. Arnalich F., Garcia-Palomero E., López J., Jiménez M., Madero R., Renart J., et al. Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 2000, 68:1942-1945.
31. Bozza F.A., Salluh J.I., Japiassu A.M., Soares M., Assis E.F., Gomes R.N., et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11:R49.
32. Hsieh L.C., Chien S.L., Huang M.S., Tseng H.F., Chang C.K. Anti-inflammatory and anticatabolic effects of short-term beta-hydroxy-beta-methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit. Asia Pac J Clin Nutr 2006, 15(4):544-550.